Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
Abstract Warfarin is the most widely used oral anticoagulant in clinical practice. The cytochrome P450 2C9 (CYP2C9), vitamin K epoxide reductase complex 1 (VKORC1), and cytochrome P450 4F2 (CYP4F2) genotypes are associated with warfarin dose requirements in China. Accurate genotyping is vital for ob...
Saved in:
Main Authors: | Defa Huang, Fangfang Xie, Shengpeng Xiao, Minyang Cai, Die Hu, Baodian Ling, Fangsheng Wang, Xuan Lin, Fangli Song, Qi Wang, Tianyu Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-80639-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prothrombin Complex Concentrate for Rapid Reversal of Warfarin Anticoagulation to Allow Neuraxial Blockade
by: Conor Skerritt, et al.
Published: (2014-01-01) -
Diffuse Alveolar Hemorrhage Associated with Warfarin Therapy
by: Bülent Kaya, et al.
Published: (2015-01-01) -
Warfarin-Associated Diaphragmatic Hernia: An Unusual Diagnosis
by: Cristina Vilhena, et al.
Published: (2015-01-01) -
Presumptive Haematomyelia Secondary to Warfarin Toxicosis in a Dog
by: Carlos Blanco, et al.
Published: (2022-01-01) -
Determining Risk Factors of Bleeding in Patients on Warfarin Treatment
by: Evren Uygungül, et al.
Published: (2014-01-01)